New link between sulfur metabolites in gut microbiome and neurodegenerative diseases revealed

A bi­par­ti­san duo of law­mak­ers is seek­ing to boost pe­di­atric drug de­vel­op­ment with new leg­is­la­tion that would pri­or­i­tize adding pe­di­atric pa­tients to tri­als for new

WASH­ING­TON – House law­mak­ers on Tues­day float­ed re­forms to a con­tro­ver­sial drug dis­count pro­gram serv­ing low-in­come pop­u­la­tions, but it’s still un­clear which poli­cies will come